Blueprint Medicines (BPMC)
(Delayed Data from NSDQ)
$107.19 USD
+0.19 (0.18%)
Updated May 3, 2024 04:00 PM ET
After-Market: $107.13 -0.06 (-0.06%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: -- |
6/2024 | $-1.40 | 29.45% |
Earnings Summary
For their last quarter, Blueprint Medicines (BPMC) reported earnings of -$1.32 per share, beating the Zacks Consensus Estimate of $-1.64 per share. This reflects a positive earnings surprise of 19.51%. Look out for BPMC's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of -$1.40 per share, reflecting a year-over-year increase of 36.07%.
Earnings History
Price & Consensus
Zacks News for BPMC
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
BPMC: What are Zacks experts saying now?
Zacks Private Portfolio Services